• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎大流行期间抗精神病药恶性综合征患者的诊断困境:急性期反应物显著增加

The diagnostic dilemma in a patient with neuroleptic malignant syndrome during the COVID-19 pandemic: A significant increase in acute phase reactants.

作者信息

Elyasi Forouzan, Zarghami Mehran, Fariborzifar Arghavan, Cheraghmakani Hamed, Shirzad Mahboobeh, Kazempour Feteme

机构信息

Sexual and Reproductive Health Research Center, Psychiatry and Behavioral Sciences Research Center Addiction Institute, Mazandaran University of Medical Sciences Sari Iran.

Department of Psychiatry, Faculty of Medicine Mazandaran University of Medical Sciences Sari Iran.

出版信息

Clin Case Rep. 2023 Aug 2;11(8):e7734. doi: 10.1002/ccr3.7734. eCollection 2023 Aug.

DOI:10.1002/ccr3.7734
PMID:37546158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10397481/
Abstract

KEY CLINICAL MESSAGE

In some patients, neuroleptic malignant syndrome is accompanied significant high levels of erythrocyte sedimentation rate (ESR), C-reactive protein (CRP).

ABSTRACT

Neuroleptic malignant syndrome (NMS) is an idiosyncratic life-threatening adverse reaction and usually triggered in response to antipsychotic drugs. In addition, leukocytosis and increased muscle enzymes levels (especially creatine phosphokinase) are observed in NMS. In addition, a transient increase in different types of acute phase reactants in NMS has been mentioned. This article describes a woman treated with haloperidol, perphenazine, escitalopram, and alprazolam because she developed catatonic symptoms after psychological stress. She suffered from NMS symptoms and had elevated CRP and ESR levels, among other signs and symptoms. Given the COVID-19 pandemic and reports of co-occurrence of catatonia and NMS and COVID-19 and elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), this patient was a diagnostic dilemma. After consultation with the consultation-liaison psychiatry units, she was managed adequately with electroconvulsive therapy and lorazepam.

摘要

关键临床信息

在一些患者中,抗精神病药恶性综合征伴有显著高水平的红细胞沉降率(ESR)和C反应蛋白(CRP)。

摘要

抗精神病药恶性综合征(NMS)是一种特异质性的、危及生命的不良反应,通常由抗精神病药物诱发。此外,在NMS中还观察到白细胞增多和肌肉酶水平升高(尤其是肌酸磷酸激酶)。另外,有提到NMS中不同类型急性期反应物会短暂增加。本文描述了一名女性患者,她在心理应激后出现紧张症症状,接受了氟哌啶醇、奋乃静、艾司西酞普兰和阿普唑仑治疗。她出现了NMS症状,除其他体征和症状外,还伴有CRP和ESR水平升高。鉴于新冠疫情以及紧张症和NMS与新冠病毒同时出现且红细胞沉降率(ESR)和C反应蛋白(CRP)升高的报道,该患者的诊断陷入困境。在与会诊联络精神科会诊后,她通过电休克治疗和劳拉西泮得到了妥善处理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2449/10397481/e69489aebcd8/CCR3-11-e7734-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2449/10397481/5662679bd1ed/CCR3-11-e7734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2449/10397481/bce72e31dabb/CCR3-11-e7734-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2449/10397481/498c76dd872e/CCR3-11-e7734-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2449/10397481/8b89863924fd/CCR3-11-e7734-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2449/10397481/e69489aebcd8/CCR3-11-e7734-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2449/10397481/5662679bd1ed/CCR3-11-e7734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2449/10397481/bce72e31dabb/CCR3-11-e7734-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2449/10397481/498c76dd872e/CCR3-11-e7734-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2449/10397481/8b89863924fd/CCR3-11-e7734-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2449/10397481/e69489aebcd8/CCR3-11-e7734-g003.jpg

相似文献

1
The diagnostic dilemma in a patient with neuroleptic malignant syndrome during the COVID-19 pandemic: A significant increase in acute phase reactants.新型冠状病毒肺炎大流行期间抗精神病药恶性综合征患者的诊断困境:急性期反应物显著增加
Clin Case Rep. 2023 Aug 2;11(8):e7734. doi: 10.1002/ccr3.7734. eCollection 2023 Aug.
2
[Acute catatonic syndrome after neuroleptic malignant syndrome].[抗精神病药恶性综合征后的急性紧张症综合征]
Encephale. 2005 Nov-Dec;31(6 Pt 1):705-9. doi: 10.1016/s0013-7006(05)82429-7.
3
[Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].[一名14岁女孩的紧张症:氯硝西泮和卡马西平治疗及10年随访]
Encephale. 2010 Feb;36(1):46-53. doi: 10.1016/j.encep.2009.01.006. Epub 2009 May 12.
4
Malignant Catatonia Versus Neuroleptic Malignant Syndrome.恶性紧张症与抗精神病药恶性综合征
Cureus. 2021 Jun 21;13(6):e15818. doi: 10.7759/cureus.15818. eCollection 2021 Jun.
5
Rapid symptom control in neuroleptic malignant syndrome with electroconvulsive therapy: A case report.电休克治疗用于快速控制抗精神病药恶性综合征症状:一例报告
Front Psychiatry. 2023 Mar 23;14:1143407. doi: 10.3389/fpsyt.2023.1143407. eCollection 2023.
6
Catatonia and Neuroleptic Malignant Syndrome in Patients With Cerebral Palsy: Two Case Reports and a Systematic Review of the Literature.脑瘫患者的紧张症和神经阻滞剂恶性综合征:两例病例报告及文献系统回顾。
J Acad Consult Liaison Psychiatry. 2023 May-Jun;64(3):277-293. doi: 10.1016/j.jaclp.2022.12.008. Epub 2022 Dec 28.
7
Detection and management of the neuroleptic malignant syndrome.抗精神病药恶性综合征的检测与管理。
Clin Pharm. 1984 May-Jun;3(3):302-7.
8
[Case report: Neuroleptic malignant syndrome and diagnostic difficulties].[病例报告:抗精神病药恶性综合征及诊断难点]
Encephale. 2016 Jun;42(3):277-80. doi: 10.1016/j.encep.2016.01.001. Epub 2016 Feb 26.
9
Catatonia versus neuroleptic malignant syndrome: the diagnostic dilemma and treatment.紧张症与抗精神病药物恶性综合征:诊断困境与治疗
Ind Psychiatry J. 2014 Jul-Dec;23(2):163-5. doi: 10.4103/0972-6748.151703.
10
Diagnostic and therapeutic challenges in neuroleptic malignant syndrome: a severe medical case.神经安定剂恶性综合征的诊断与治疗挑战:一个严重的医疗案例。
Riv Psichiatr. 2020 Jul-Aug;55(4):236-239. doi: 10.1708/3417.34000.

本文引用的文献

1
The management challenges of a case with Flupentixol-induced neuroleptic malignant syndrome.氟哌啶醇致神经阻滞剂恶性综合征病例的管理挑战。
Neuropsychopharmacol Rep. 2023 Mar;43(1):154-159. doi: 10.1002/npr2.12315. Epub 2022 Dec 30.
2
Concurrent catatonia and COVID-19 infection - An experiential account of challenges and management of cases from a tertiary care psychiatric hospital in India.同时患有紧张症和 COVID-19 感染 - 印度一家三级精神保健医院对病例的挑战和管理的经验性报告。
Asian J Psychiatr. 2022 Mar;69:103004. doi: 10.1016/j.ajp.2022.103004. Epub 2022 Jan 4.
3
A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies.
对 SARS-CoV-2(COVID-19)复杂性、新兴变异体以及治疗干预和疫苗接种策略的批判性分析。
Biomed Pharmacother. 2022 Feb;146:112550. doi: 10.1016/j.biopha.2021.112550. Epub 2021 Dec 15.
4
COVID-19 and Catatonia: A Case Series and Systematic Review of Existing Literature.新型冠状病毒肺炎与紧张症:病例系列及现有文献的系统评价
J Acad Consult Liaison Psychiatry. 2021 Nov-Dec;62(6):645-656. doi: 10.1016/j.jaclp.2021.04.003. Epub 2021 Apr 20.
5
Neuroleptic malignant syndrome in patients with COVID-19.新冠病毒感染者的神经阻滞剂恶性综合征。
Am J Emerg Med. 2020 Oct;38(10):2243.e1-2243.e3. doi: 10.1016/j.ajem.2020.05.042. Epub 2020 May 22.
6
Catatonia and the immune system: a review.紧张症与免疫系统:综述
Lancet Psychiatry. 2019 Jul;6(7):620-630. doi: 10.1016/S2215-0366(19)30190-7. Epub 2019 Jun 10.
7
Olanzapine-Induced Neuroleptic Malignant Syndrome.奥氮平所致的抗精神病药恶性综合征
Iran J Med Sci. 2017 May;42(3):306-309.
8
Malignant Catatonia Warrants Early Psychiatric-Critical Care Collaborative Management: Two Cases and Literature Review.恶性紧张症需要早期精神科-重症监护协作管理:两例病例及文献综述
Case Rep Crit Care. 2017;2017:1951965. doi: 10.1155/2017/1951965. Epub 2017 Jan 30.
9
Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma.抗精神病药恶性综合征还是紧张症?试图解决紧张症难题。
Psychopharmacology (Berl). 2015 Jan;232(1):1-5. doi: 10.1007/s00213-014-3807-8. Epub 2014 Nov 20.
10
Neuroleptic malignant syndrome: a review for neurohospitalists.抗精神病药恶性综合征:给神经科住院医师的综述
Neurohospitalist. 2011 Jan;1(1):41-7. doi: 10.1177/1941875210386491.